Post-RFA Mortality Up for ESRD Patients Who Receive Dialysis

This article originally appeared here.
Share this content:
Post-RFA Mortality Up for ESRD Patients Who Receive Dialysis
Post-RFA Mortality Up for ESRD Patients Who Receive Dialysis

MONDAY, March 20, 2017 (HealthDay News) -- For patients with end-stage renal disease (ESRD), receipt of hemodialysis (HD) is associated with increased mortality after radiofrequency ablation (RFA) for hepatocellular carcinoma, according to a study published online March 7 in the Journal of Gastroenterology and Hepatology.

Masaya Sato, from the University of Tokyo, and colleagues used a nationwide database to examine in-hospital mortality and hemorrhagic complications following RFA among patients on HD for ESRD. For each patient enrolled, up to four non-dialyzed patients were randomly selected. The authors compared in-hospital mortality and hemorrhagic complications between dialyzed and non-dialyzed patients (437 and 1,345 patients, respectively) following RFA.

The researchers found that mortality was significantly lower in those aged ≤70 years versus older patients (P = 0.02). Dialyzed ESRD patients had significantly higher in-hospital mortality than non-dialyzed patients (1.1 versus 0.15 percent; odds ratio, 7.77; P < 0.001). There was a significant difference in hemorrhagic complications between dialyzed ESRD and non-dialyzed patients (3.4 and 0.87 percent, respectively; odds ratio, 4.75; P < 0.001).

"In-hospital mortality following RFA was higher in dialyzed ESRD patients than in non-dialyzed patients," the authors write. "The indications for RFA in dialysis-dependent patients should be considered carefully."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease



Sign up for myCME e-newsletters




More in Home

Medicaid Expansion Ups Preemptive Listing for Kidney Transplant

Medicaid Expansion Ups Preemptive Listing for Kidney Transplant

From pre- to post-expansion period, 59 percent relative increase in Medicaid-covered preemptive listings

BCG Vaccine Tied to Reduced Hyperglycemia in Type 1 Diabetes

BCG Vaccine Tied to Reduced Hyperglycemia in Type ...

Systemic shift in glucose metabolism from oxidative phosphorylation to aerobic glycolysis

Many Physicians Not Prepared for End-of-Life Talks With Patients

Many Physicians Not Prepared for End-of-Life Talks With ...

Additional training, reimbursement may foster these critical conversations, authors say

is free, fast, and customized just for you!




Already a member?

Sign In Now »